Skip to main content
Clinical Trials/TCTR20200201003
TCTR20200201003
Active, not recruiting
未知

A New Method for Evaluating Oxidative Stress in Behçet Disease: Thiol/Disulfide Homeostasis

Self sponsor0 sites60 target enrollmentFebruary 1, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Active Behcet DiseaseInactive Behcet Disease
Sponsor
Self sponsor
Enrollment
60
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2020
End Date
February 3, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Self sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants in OABD and OIBD groups were followed up or recently diagnosed by the Ophthalmology Department of Fırat University College of Medicine. Likewise, sex and age matched healthy participants were also included as controls

Exclusion Criteria

  • systemic administration of steroids or immunosuppressive agents within the last 30 days, presence of another disease increasing oxidative stress state, alcohol abuse, ingestion of vitamin or another medicine having an oxidative effect in the previous six months, body mass index higher than 30 kg/m2, end stage BD, and intense cataract that restricted the examination of fundus.

Outcomes

Primary Outcomes

Not specified

Similar Trials